Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Lake City › NPI 1992751879
Hospital

Notami Hospitals of Florida INC

Notami Hospitals of Florida INC was paid $19.32M by Medicaid between Jan 2018 and Dec 2024, across 193 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.

33Billing provider infoNOTAMI HOSPITALS OF FLORIDA INC
LAKE CITY, FL 32055
33aNPI1992751879assigned 05/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.32M
24GClaims764,443
24DCodes billed193
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#17 of 163
Median peer was paid$4.77M
This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201835,837$517K
201977,917$1.08M
2020109,984$1.79M
2021177,500$4.07M
2022185,949$5.57M
2023112,912$3.93M
2024incomplete64,344$2.36M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 42% 89,262 79,427 $8.12M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 40,159 34,109 $2.82M
74176 Computed tomography, abdomen and pelvis; without contrast material 7.9% 9,990 8,526 $1.53M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.1% 12,406 11,605 $1.18M
70450 Computed tomography, head or brain; without contrast material 4.7% 8,661 6,969 $904K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.9% 9,155 7,300 $562K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.3% 5,379 5,037 $445K
80047 2.2% 18,360 14,843 $425K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.1% 1,871 1,685 $415K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.0% 3,671 3,407 $388K
71275 Computed tomographic angiography, chest, with contrast material <1% 741 661 $166K
80053 Comprehensive metabolic panel <1% 19,310 15,933 $163K
181 more codes
96361 Intravenous infusion, hydration; each additional hour <1% 2,252 $147K
87070 <1% 6,108 $114K
J7050 Infusion, normal saline solution, 250 cc <1% 6,325 $111K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,196 $77K
81003 <1% 12,355 $76K
A9270 Non-covered item or service <1% 12,049 $71K
71045 Radiologic examination, chest; single view <1% 27,054 $62K
87430 <1% 15,029 $53K
12001 <1% 556 $47K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 24,433 $46K
72125 Computed tomography, cervical spine; without contrast material <1% 1,641 $46K
72131 <1% 587 $42K
73610 <1% 1,495 $42K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 10,571 $41K
73630 <1% 2,039 $38K
85027 <1% 45,286 $37K
71250 <1% 1,046 $37K
71046 Radiologic examination, chest; 2 views <1% 3,361 $36K
73130 <1% 1,468 $36K
81001 <1% 9,372 $36K
73562 <1% 1,757 $36K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,115 $35K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 898 $34K
80048 Basic metabolic panel (calcium, ionized) <1% 5,325 $33K
87449 <1% 2,205 $31K
73030 <1% 1,595 $29K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 232 $29K
84702 <1% 1,496 $27K
G0378 Hospital observation service, per hour <1% 3,494 $25K
73110 <1% 1,062 $24K
12011 <1% 272 $24K
84484 <1% 21,613 $23K
80076 <1% 15,639 $23K
84703 <1% 3,557 $22K
74018 <1% 1,277 $20K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 19,532 $20K
80306 <1% 2,798 $20K
76641 <1% 214 $19K
36415 Collection of venous blood by venipuncture <1% 1,668 $19K
82803 <1% 12,538 $18K
87077 <1% 2,749 $17K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,487 $17K
93976 <1% 1,688 $17K
12002 <1% 261 $17K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 642 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,168 $15K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 294 $15K
72100 <1% 948 $15K
87040 <1% 14,966 $15K
76830 Ultrasound, transvaginal <1% 1,040 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,741 $13K
87280 <1% 886 $12K
J7030 Infusion, normal saline solution , 1000 cc <1% 13,522 $11K
83735 <1% 12,189 $10K
70486 <1% 165 $10K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,181 $10K
10060 <1% 157 $10K
73140 <1% 329 $10K
85610 <1% 10,724 $9K
73502 <1% 565 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 9,185 $9K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 347 $9K
83880 <1% 7,002 $9K
82550 <1% 7,614 $8K
73090 <1% 306 $8K
85730 <1% 6,522 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,035 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 764 $7K
83690 <1% 15,842 $7K
J8540 Dexamethasone, oral, 0.25 mg <1% 1,931 $7K
93971 <1% 599 $7K
77067 Screening mammography, bilateral, including computer-aided detection <1% 274 $7K
84443 Thyroid stimulating hormone (TSH) <1% 3,903 $7K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 268 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 9,990 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 17,635 $6K
83605 <1% 16,042 $5K
71101 <1% 145 $5K
73080 <1% 386 $5K
73590 <1% 351 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 535 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,847 $4K
73700 <1% 47 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 611 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 45 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,684 $4K
80061 Lipid panel <1% 1,713 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 243 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 734 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,458 $3K
82330 <1% 597 $3K
72050 <1% 135 $3K
70496 <1% 15 $3K
J2704 Injection, propofol, 10 mg <1% 272 $3K
82565 <1% 275 $3K
84100 <1% 2,116 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,389 $3K
76770 <1% 64 $3K
87186 <1% 2,491 $3K
J1815 Injection, insulin, per 5 units <1% 864 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 55 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,896 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 794 $2K
81025 <1% 2,872 $2K
73560 <1% 88 $2K
36430 <1% 32 $2K
72040 <1% 75 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,312 $1K
82553 <1% 341 $1K
96376 <1% 1,568 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 81 $1K
73600 <1% 17 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,188 $1K
80320 <1% 310 $897.14
86140 <1% 2,377 $830.53
82248 <1% 1,496 $792.65
85378 <1% 821 $755.25
70498 <1% 18 $570.61
87205 <1% 1,357 $566.59
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 126 $563.65
86885 <1% 555 $556.03
73552 <1% 14 $554.97
85651 <1% 1,390 $551.51
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 770 $528.35
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 562 $528.35
82077 <1% 917 $457.49
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 15 $429.55
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 629 $396.02
90715 <1% 750 $375.26
J0561 Injection, penicillin g benzathine, 100,000 units <1% 168 $350.19
87807 <1% 611 $315.02
72070 <1% 72 $312.94
74019 <1% 17 $297.50
83036 Hemoglobin; glycosylated (A1C) <1% 885 $275.36
29125 <1% 33 $263.39
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 173 $241.23
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 781 $212.04
82607 <1% 85 $179.89
87400 <1% 3,147 $148.35
84439 <1% 200 $144.93
70360 <1% 13 $141.58
73060 <1% 16 $132.98
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing <1% 271 $125.45
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,039 $119.38
85379 <1% 101 $117.81
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 62 $102.48
77066 Tomosynthesis, mammo <1% 42 $97.25
P9016 Red blood cells, leukocytes reduced, each unit <1% 35 $93.20
86920 <1% 21 $88.41
J1650 Injection, enoxaparin sodium, 10 mg <1% 274 $60.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 413 $58.74
J2060 Injection, lorazepam, 2 mg <1% 826 $36.39
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 3,057 $21.34
84480 <1% 208 $16.04
86901 <1% 699 $6.92
36600 <1% 16 $4.53
C9113 Injection, pantoprazole sodium, per vial <1% 272 $3.74
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 311 $0.17
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 495 $0.00
80329 0% 332 $0.00
83615 0% 15 $0.00
76801 0% 53 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 216 $0.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 0% 43 $0.00
J3490 Unclassified drugs 0% 28 $0.00
82150 0% 39 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 121 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 101 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 16 $0.00
87088 0% 14 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 907 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 186 $0.00
82140 0% 232 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 57 $0.00
86900 0% 588 $0.00
S0028 Injection, famotidine, 20 mg 0% 64 $0.00
87420 0% 29 $0.00
87210 0% 45 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 56 $0.00
82009 0% 39 $0.00
82310 0% 40 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIM (CFO)
Same official

Other billing entities under WILLIAMS, KIM

Full network →
ProviderLocationPaid
TLC Operations, INC.Raleigh, NC$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.